Trauma & Intensive Care Community Services Diagnosis & Investigation Medical & Surgical Specialized Support Service Health Rehabilitation Download Our Brochures Business is a marketing discipline focused on growing visibility in organic (non-paid) technic required. Click here to download Contact Info 80 Broklyn Golden Street, New York. USA +92 (300) 7101235 info@themerange.net Mon – Sat 8:00 – 6:30, Sunday – CLOSED Intensive Care Behind the word mountains, far from the countries Vokalia and Consonantia, there live the blind texts. Separated they live in Bookmarksgrove right at the coast of the Semantics, a large language ocean. A small river named Duden flows by their Place and supplies it with the necessary regelialia. It is a paradisematic country, in which roasted parts of sentences fly into your mouth. Even the all-powerful Pointing has no control about the blind texts it is an almost unorthographic life One day however a small line of blind text by the name of Lorem Ipsum decided to leave for the far World of Grammar. Treatment Plans Trauma & intensive care$59 Trauma & intensive care$59 Aged Care$29 Aged Care$29 Community Services$25 Community Services$25 Diagnosis & Investigation$48 Diagnosis & Investigation$48 Medical & Surgical$82 Medical & Surgical$82 Mental Health$74 Mental Health$74 Rehabilitation$24 Rehabilitation$24 Specialized Support Service$19 Specialized Support Service$19 Good physician treats the disease Behind the word mountains, far from the countries Vokalia and Consonantia, there live the blind texts. Separated they live in Bookmarksgrove right at the coast of the Semantics, a large language ocean. A small river named Duden flows by their place and supplies it with the necessary regelialia. It is a paradisematic country, in which roasted parts of sentences fly into your mouth. Trauma & intensive care Medical & Surgical Aged Care Mental Health Community Services Rehabilitation Diagnosis & Investigation Specialized Support Service

Trauma & Intensive Care Community Services Diagnosis & Investigation Medical & Surgical Specialized Support Service Health Rehabilitation Download Our Brochures Business is a marketing discipline focused on growing visibility in organic (non-paid) technic required. Click here to download Contact Info 80 Broklyn Golden Street, New York. USA +92 (300) 7101235 info@themerange.net Mon – Sat 8:00 – 6:30, Sunday – CLOSED Intensive Care Behind the word mountains, far from the countries Vokalia and Consonantia, there live the blind texts. Separated they live in Bookmarksgrove right at the coast of the Semantics, a large language ocean. A small river named Duden flows by their Place and supplies it with the necessary regelialia. It is a paradisematic country, in which roasted parts of sentences fly into your mouth. Even the all-powerful Pointing has no control about the blind texts it is an almost unorthographic life One day however a small line of blind text by the name of Lorem Ipsum decided to leave for the far World of Grammar. Treatment Plans Trauma & intensive care$59 Trauma & intensive care$59 Aged Care$29 Aged Care$29 Community Services$25 Community Services$25 Diagnosis & Investigation$48 Diagnosis & Investigation$48 Medical & Surgical$82 Medical & Surgical$82 Mental Health$74 Mental Health$74 Rehabilitation$24 Rehabilitation$24 Specialized Support Service$19 Specialized Support Service$19 Good physician treats the disease Behind the word mountains, far from the countries Vokalia and Consonantia, there live the blind texts. Separated they live in Bookmarksgrove right at the coast of the Semantics, a large language ocean. A small river named Duden flows by their place and supplies it with the necessary regelialia. It is a paradisematic country, in which roasted parts of sentences fly into your mouth. Trauma & intensive care Medical & Surgical Aged Care Mental Health Community Services Rehabilitation Diagnosis & Investigation Specialized Support Service

Actinium PRRT Therapy Prostate Cancer Lymphoma Liver Cancer Breast Cancer Lung Cancer Benign Disease Radiology Services Cancer Diagnosis Oncology Department What is Actinium PRRT Therapy? Actinium PRRT (Peptide Receptor Radionuclide Therapy) is a type of targeted therapy used in the treatment of certain types of cancer, particularly neuroendocrine tumors (NETs). PRRT involves the use of a radioactive substance combined with a targeting molecule (peptide) that specifically binds to receptors on the surface of cancer cells. The radioactive substance most commonly used in Actinium PRRT is Actinium-225 (Ac-225), which emits alpha particles. Alpha particles have high energy and can travel only a short distance in tissue, making them effective in delivering radiation to targeted cancer cells while minimizing damage to surrounding healthy tissues. Treatments At Nuclear Care MD, we understand that each patient is unique and requires an individualized approach to treatment. Our multidisciplinary team of experts collaborates to design personalized treatment plans tailored to meet your specific needs. We take into account factors such as your medical history, diagnostic results, and overall health to ensure the most effective and safest course of treatment. From your initial consultation to post-treatment follow-up, we are here for you every step of the way. We provide comprehensive care that focuses not only on your physical well-being but also your emotional support and overall quality of life. Our compassionate staff is dedicated to addressing your concerns and providing the support you need throughout your treatment journey. At Nuclear care MD If you or a loved one are seeking advanced and effective cancer treatment, we invite you to explore Actinium PRRT Therapy at Nuclear Care MD. Our dedicated team is ready to answer any questions you may have and provide you with the support you need during this challenging time. damage to surrounding healthy tissues.

Lutetium PRRT Therapy Prostate Cancer Lymphoma Liver Cancer Breast Cancer Lung Cancer Benign Disease Radiology Services Cancer Diagnosis Oncology Department What is Lutetium PRRT Therapy? Peptide Receptor Radionuclide Therapy, or lutetium PRRT, is a type of targeted radionuclide therapy used to treat some neuroendocrine tumours. It makes use of lutetium-177 (Lu-177), a radioactive compound that is bound to a peptide molecule and specifically targets receptors on the surface of neuroendocrine tumour cells. Rare, slow-growing tumours that develop from cells in the endocrine and neurological systems are known as neuroendocrine tumours. On their cell surface, they frequently have high somatostatin receptor expression. By delivering a radioactive payload specifically to the tumour cells with lutetium PRRT, the malignant cells are destroyed with precision while causing the least amount of harm to healthy tissues. Treatments Our skilled team of medical professionals, including experienced nuclear medicine physicians, oncologists, and radiologists, are at the forefront of Lutetium PRRT Therapy. With their extensive knowledge and expertise, we ensure that our patients receive the highest quality of care. At Nuclear Care MD, we understand that every patient’s journey is unique. We take the time to conduct thorough evaluations and develop personalized treatment plans tailored to each individual’s specific needs. Our goal is to optimize the effectiveness of Lutetium PRRT Therapy while prioritizing patient comfort and well-being. At Nuclear Care MD We are dedicated to improving the lives of our patients through the innovative use of Lutetium PRRT Therapy. Our commitment to excellence, personalized care, and comprehensive support sets us apart. If you or a loved one have been diagnosed with any of the aforementioned conditions, we encourage you to explore the potential benefits of Lutetium PRRT Therapy. Contact Nuclear Care MD today to schedule a consultation and take the first step towards a brighter, healthier future.

Lutetium PSMA Therapy Prostate Cancer Lymphoma Liver Cancer Breast Cancer Lung Cancer Cancer Diagnosis Oncology Department Targeted Alpha Therapy Beta Therapy Pluvicto Therapy What is Lutetium PSMA Therapy? Advanced prostate cancer is treated with lutetium PSMA therapy, sometimes referred to as lutetium-177 prostate-specific membrane antigen therapy or lutetium-177 PSMA therapy. The protein known as PSMA, or prostate-specific membrane antigen, is present on the outer surface of prostate cancer cells. Lutetium In PSMA therapy, a chemical that precisely targets and binds to the PSMA protein on prostate cancer cells is used in conjunction with the radioactive isotope lutetium-177. This minimises radiation harm to neighbouring healthy tissues while allowing precision radiation delivery to the cancer cells Treatments During the Lutetium PSMA Therapy procedure, a small amount of Lutetium-177 is injected into your bloodstream. The radioactive molecules specifically seek out and attach themselves to PSMA receptors on cancer cells, delivering a high dose of radiation directly to the tumor sites. This targeted approach allows for effective destruction of cancer cells while minimizing side effects. Our experienced and compassionate medical staff will closely monitor your progress throughout the treatment process. We prioritize your comfort and safety, providing a supportive environment to help you feel at ease during your therapy sessions. Our team is always available to address any questions or concerns you may have, ensuring that you are well-informed and empowered throughout your treatment journey. At Nuclear care As leaders in the field of nuclear medicine, we remain at the forefront of advancements in Lutetium PSMA Therapy. Our commitment to continuous research and development ensures that we provide our patients with the latest innovations and best-in-class care. If you or your loved one is seeking an advanced and effective treatment option for prostate cancer, Nuclear Care MD is here to support you. Contact us today to schedule a consultation and learn more about how Lutetium PSMA Therapy can make a difference in your cancer treatment journey. PSMA Therapy Success Stories: Nuclear Care The success of PSMA therapy in treating prostate cancer has been demonstrated in numerous case studies and clinical trials. One such example is the case of a 73-year-old man with metastatic prostate cancer who had exhausted all other treatment options. After undergoing PSMA therapy, the patient experienced a significant reduction in his prostate-specific antigen (PSA) levels, a marker of prostate cancer activity, and a noticeable improvement in his overall health and well-being. Another success story involves a 68-year-old man with advanced prostate cancer that had spread to his bones. Despite previous treatments, the cancer continued to progress, and the patient was experiencing debilitating pain and discomfort. However, after receiving PSMA therapy, the patient’s pain was significantly reduced, and subsequent imaging scans showed a marked decrease in the size and activity of the metastatic lesions. These are just a few examples of the positive outcomes observed with PSMA therapy. As more patients undergo this treatment, the growing body of evidence continues to demonstrate the potential of this innovative approach to prostate cancer management.

IODINE MIBG Therapy Prostate Cancer Lymphoma Liver Cancer Breast Cancer Lung Cancer Benign Disease Radiology Services Cancer Diagnosis Oncology Department What is IODINE MIBG Therapy? Iodine MIBG therapy, also known as iodine-131 metaiodobenzylguanidine therapy, is a specialized form of targeted radiation therapy used in the treatment of certain types of cancer, particularly neuroblastoma and pheochromocytoma. It involves the administration of a radioactive form of iodine, known as iodine-131, which is attached to a compound called metaiodobenzylguanidine (MIBG). MIBG is structurally similar to norepinephrine, a chemical that is taken up by neuroendocrine tumor cells. By attaching radioactive iodine to MIBG, it creates a targeted radioactive compound that is selectively taken up by the cancer cells. Once the radioactive iodine accumulates in the tumor cells, it emits radiation, damaging the DNA and other cellular structures, thereby killing the cancer cells. Treatments Iodine MIBG therapy, also known as iodine-131 metaiodobenzylguanidine therapy, is a specialized form of targeted radiation therapy used in the treatment of certain types of cancer, particularly neuroblastoma and pheochromocytoma. It involves the administration of a radioactive form of iodine, known as iodine-131, which is attached to a compound called metaiodobenzylguanidine (MIBG). MIBG is structurally similar to norepinephrine, a chemical that is taken up by neuroendocrine tumor cells. By attaching radioactive iodine to MIBG, it creates a targeted radioactive compound that is selectively taken up by the cancer cells. Once the radioactive iodine accumulates in the tumor cells, it emits radiation, damaging the DNA and other cellular structures, thereby killing the cancer cells. At Nuclear Care MD We are proud to offer Iodine MIBG Therapy as a transformative treatment option, providing hope and improved outcomes for patients facing neuroendocrine tumors. Our commitment to excellence in care, combined with cutting-edge technology and compassionate support, sets us apart as leaders in the field. Take the first step towards a brighter future. Contact us today to learn more about Iodine MIBG Therapy and schedule a consultation with our dedicated team of experts at Nuclear Care MD. Together, let’s embark on a journey towards healing and renewed hope.

Alpha PSMA Therapy Prostate Cancer Lymphoma Liver Cancer Breast Cancer Lung Cancer Benign Disease Radiology Services Cancer Diagnosis Oncology Department . What is Alpha PSMA Therapy? Alpha PSMA therapy is an innovative and targeted treatment approach that harnesses the power of alpha particles to combat prostate cancer. It is specifically designed for patients with metastatic castration-resistant prostate cancer (mCRPC) who have exhausted other treatment options. The therapy revolves around the prostate-specific membrane antigen (PSMA), a protein found on the surface of prostate cancer cells. By using a radioactive substance called an alpha emitter, the treatment delivers highly potent alpha particles directly to the cancer cells, minimizing damage to healthy tissues. How does Alpha PSMA Therapy work? Our treatment process begins with a comprehensive assessment of each patient’s unique condition. Our experienced physicians will conduct thorough evaluations and consultations to determine the most suitable treatment plan. We prioritize open communication and collaboration, ensuring that patients and their families are fully informed and actively involved in the decision-making process.Our treatment process begins with a comprehensive assessment of each patient’s unique condition. Our experienced physicians will conduct thorough evaluations and consultations to determine the most suitable treatment plan. We prioritize open communication and collaboration, ensuring that patients and their families are fully informed and actively involved in the decision-making process. During Alpha PSMA Therapy, a radiopharmaceutical agent is administered intravenously. This specialized agent binds to prostate-specific membrane antigen (PSMA) receptors on cancer cells, delivering the alpha particles directly to the tumor sites. The highly targeted radiation effectively destroys cancer cells while sparing healthy tissues, minimizing the impact on quality of life. At Nuclear Care MD we understand that prostate cancer treatment is not just about eradicating cancer cells. It’s also about supporting the overall well-being of our patients. Our compassionate team provides comprehensive care that encompasses physical, emotional, and psychological aspects. We are here to address your concerns, answer your questions, and provide guidance throughout your treatment journey. We are proud to offer Alpha PSMA Therapy as part of our commitment to delivering the highest standard of care. Our facility is equipped with advanced technology and staffed by skilled professionals who are passionate about improving patient outcomes. With Nuclear Care MD, you can trust that you are receiving world-class treatment in a supportive and patient-centered environment.

Transarterial Radioembolisation Prostate Cancer Lymphoma Liver Cancer Breast Cancer Lung Cancer Benign Disease Radiology Services Cancer Diagnosis Oncology Department What is Transarterial Radioembolisation ? A minimally invasive medical procedure called transarterial radioembolization (TARE) is used to treat liver tumours, particularly those caused by hepatocellular carcinoma (HCC) and metastatic liver cancer. It entails the precise injection of microscopic radioactive beads known as microspheres right into the blood arteries that feed the tumour. In order to access the liver during the surgery, a catheter is placed into the patient’s groyne and advanced into the blood vessels. The radioactive microspheres are injected through the catheter and transported to the tumour site by the bloodstream. The microspheres get stuck inside the tumor’s tiny blood capillaries, where they release radiation that kills the malignant cells. Treatments At Nuclear Care MD, we understand that every patient’s journey is unique. Our experienced team of physicians, radiologists, and nuclear medicine specialists works collaboratively to tailor a personalized treatment plan for each individual. We believe in a comprehensive approach that prioritizes patient comfort, safety, and successful outcomes.At Nuclear Care MD, we understand that every patient’s journey is unique. Our experienced team of physicians, radiologists, and nuclear medicine specialists works collaboratively to tailor a personalized treatment plan for each individual. We believe in a comprehensive approach that prioritizes patient comfort, safety, and successful outcomes. We are proud to utilize state-of-the-art technology and equipment in our TARE procedures. Our advanced imaging techniques and precision-guided delivery systems allow for accurate tumor targeting, minimizing the impact on healthy liver tissue. This leads to enhanced treatment efficacy and reduced side effects, ultimately improving patient quality of life.We are proud to utilize state-of-the-art technology and equipment in our TARE procedures. Our advanced imaging techniques and precision-guided delivery systems allow for accurate tumor targeting, minimizing the impact on healthy liver tissue. This leads to enhanced treatment efficacy and reduced side effects, ultimately improving patient quality of life. At Nuclear Care MD Take control of your health and explore the possibilities of Transarterial Radioembolization at Nuclear Care MD. Our dedicated team is ready to guide you through every step of your treatment, from initial consultation to post-treatment care. Contact us today to schedule an appointment and discover how Transarterial Radioembolization can make a difference in your life.